Efficacy of Ultrasound-Guided Hydrodissection in Carpal Tunnel Syndrome

Summary

The aim of our study is to determine the effectiveness of US-guided hydrodissection of the median nerve in different contents and volumes in patients diagnosed with mild to moderate carpal tunnel syndrome.

Conditions

• Musculoskeletal Diseases
• Median Nerve Disease
• Carpal Tunnel Syndrome
• Ultrasound-Guided Injection

Interventions

PROCEDURE

Ultrasound-guided Hydrodissection (HD) with 5 cc 5% Dextrose

The median nerve will be defined at the proximal entrance of the carpal tunnel (scaphoid-pisiform plane). Under the ulnar approach with the in-plane technique, first it was planned to hydrodissect the median nerve from the retinaculum superiorly and then from the flexor tendons inferiorly, using 5 cc of 5% dextrose.

PROCEDURE

Ultrasound-guided Hydrodissection (HD) with 5 cc Normal Saline

The median nerve will be defined at the proximal entrance of the carpal tunnel (scaphoid-pisiform plane). Under the ulnar approach with the in-plane technique, first it was planned to hydrodissect the median nerve from the retinaculum superiorly and then from the flexor tendons inferiorly, using 5 cc normal saline.

PROCEDURE

Ultrasound-guided Hydrodissection (HD) with 10 cc 5% Dextrose

The median nerve will be defined at the proximal entrance of the carpal tunnel (scaphoid-pisiform plane). Under the ulnar approach with the in-plane technique, first it was planned to hydrodissect the median nerve from the retinaculum superiorly and then from the flexor tendons inferiorly, using 10 cc 5% dextrose.

PROCEDURE

Ultrasound-guided Hydrodissection (HD) with 10 cc Normal Saline

The median nerve will be defined at the proximal entrance of the carpal tunnel (scaphoid-pisiform plane). Under the ulnar approach with the in-plane technique, first it was planned to hydrodissect the median nerve from the retinaculum superiorly and then from the flexor tendons inferiorly, using 10 cc normal saline.

Sponsors & Collaborators

• Afyonkarahisar Health Sciences University

  lead OTHER

Principal Investigators

• Nuran EYVAZ, MD · Afyonkarahisar Health Sciences University

• Ali İzzet AKÇİN, MD · Afyonkarahisar Health Sciences University

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Model

PARALLEL

Eligibility

Min Age

20 Years

Max Age

60 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-09-20

Primary Completion

2023-12-20

Completion

2024-01-10

Countries

• Turkey (Türkiye)

Study Locations